Almagel excluded to be used as reflux esophagitis treatment

Since the ‘reflux esophagitis’ indication of almagate drugs, including Almagel(Yuhan Corporation), has been excluded since the 17^th of the last month, the relevant suspension market has been worried.

In order to fill in the vacancy of almagate drugs, which had been largely prescribed for reflux esophagitis, its competing companies have started to target it with other, such as sodium alginate d...